✦ LIBER ✦

Dose-intensification and stem cell transplantation (SCT) for histologically transformed low-grade follicular non-hodgkin lymphoma (NHL): a single center experience

✍ Scribed by M. Vusirikala; S. Brandt; W. Chinratanalab; J.P. Greer; M. Jagasia; A. Kassim; S. Mineshi; D.S. Morgan; K. Ruffner; S.G. Friedrich; Y. Shyr; S.A. Goodman

Book ID: 116277624
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 52 KB
Volume: 10
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2003.12.087

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allogeneic or autologous stem cell trans

Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma: a single-centre experience

✍ D. Nachbaur; W. Oberaigner; E. Fritsch; W. Nussbaumer; G. Gast 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

Long-term results of autologous stem cel

Long-term results of autologous stem cell transplantation for Hodgkin’s disease (HD) and low-/intermediate-grade B non-Hodgkin’s lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR)

✍ David Nachbaur; Hildegard T. Greinix; Elisabeth Koller; Otto Krieger; Werner Lin 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 175 KB

Results of 10-Year Single Center Experie

Results of 10-Year Single Center Experience with Pharmacokinetics Directed Intravenous Busulfan, Cyclophosphamide and Etoposide Preparative Regimen in Autologous Hematopoietic Stem Cell Transplantation for Intermediate and High Grade Non-Hodgkin Lymphoma

✍ Patil, Neha R.; Salzman, Donna; Donnellan, William; Vaughan, William 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 247 KB

PCR detection of residual Bcl-2/IgH-posi

PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma

✍ Mahé, B; Milpied, N; Mellerin, M P; Moreau, P; Morineau, N; Vigier, M; Haroussea 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 132 KB

The city of hope experience with novel t

The city of hope experience with novel transplant regimens that incorporate standard and escalated dose 90YTTRIUM ibritumomab tiuxetan (90Y-Zevalin®) radioimmunotherapy (RIT) for autologous stem cell transplantation (ASCT) in patients with B-cell non-Hodgkin’s lymphoma (NHL): targeted intensification without increased toxicity and elimination of total body irradiation (TBI)

✍ A. Nademanee; H. Fung; A. Molina; A. Krishnan; R. Rodriguez; L. Popplewell; R.T. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 56 KB